Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. KalVista Pharmaceuticals Inc shares valued at $25,553 were sold by Yea Christopher on Feb 18 ’25. At $9.82 per share, Yea Christopher sold 2,601 shares. The insider’s holdings dropped to 92,745 shares worth approximately $0.99 million following the completion of this transaction.
Also, Audhya Paul K. sold 3,125 shares, netting a total of over 30,701 in proceeds. Following the sale of shares at $9.82 each, the insider now holds 100,334 shares.
Before that, Palleiko Benjamin L had sold 5,104 shares from its account. In a trade valued at $50,143, the CHIEF EXECUTIVE OFFICER traded KalVista Pharmaceuticals Inc shares for $9.82 each. Upon closing the transaction, the insider’s holdings decreased to 5,104 shares, worth approximately $2.99 million.
As published in their initiating research note from JMP Securities on January 31, 2025, KalVista Pharmaceuticals Inc [KALV] has been a Mkt outperform and the price target has been revised to $19. Analysts at TD Cowen started covering the stock with ‘”a Buy”‘ outlook in a report released in early January. As of December 18, 2024, BofA Securities has initiated its “Buy” rating for KALV. Earlier on June 15, 2020, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for KALV stock.
Analyzing KALV Stock Performance
During the last five days, there has been a surge of approximately 15.53%. Over the course of the year, KalVista Pharmaceuticals Inc shares have jumped approximately 26.45%. Shares of the company reached a 52-week high of $11.00 on 02/19/25 and a 52-week low of $7.30 on 01/13/25. A 50-day SMA is recorded $8.87, while a 200-day SMA reached $11.13. Nevertheless, trading volume fell to 0.52 million shares from 0.28 million shares the previous day.
Support And Resistance Levels for KalVista Pharmaceuticals Inc (KALV)
According to the 24-hour chart, there is a support level at 9.90, which, if violated, would cause prices to drop to 9.09. In the upper region, resistance lies at 11.26. The next price resistance is at 11.81. RSI (Relative Strength Index) is 72.25 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.59, which suggests the price will decrease in the coming days. Percent R is at 12.45%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
